Mitchell Mutz is a Senior Principal at Samsara BioCapital with over 25 years in biotech entrepreneurship and investing. He previously held roles at Vivo Capital and Roche Venture Fund, and co-founded Amplyx Pharmaceuticals.
At firms with a similar stage, sector and check size.





One email when Mitchell's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckMitchell Mutz is a Senior Principal at Samsara BioCapital with over 25 years in biotech entrepreneurship and investing. He previously held roles at Vivo Capital and Roche Venture Fund, and co-founded Amplyx Pharmaceuticals.
Mitchell Mutz invests through Samsara BioCapital, which writes checks of $10M to $30M at seed, series a, series b.
Email [email protected], the firm's inbox for founders, and name Mitchell in the subject. A warm intro from a founder Samsara BioCapital backed works better.
Principal Scientist at Labcyte; co-founder, president, and chief scientific officer at Amplyx Pharmaceuticals, Inc.; Senior Investment Director at Roche Venture Fund; Entrepreneur Partner at Vivo Capital; founding team and Principal Scientist at Labcyte.
Last updated 2026-10-15. Is this you? Ask for a correction.